Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study


Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., ...More

OCULAR IMMUNOLOGY AND INFLAMMATION, vol.25, no.1, pp.62-70, 2017 (SCI-Expanded) identifier identifier identifier

Abstract

Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.